checkmate 025: phase 3 trial of nivolumab for advanced kidney cancer
Published 8 years ago • 228 plays • Length 3:52Download video MP4
Download video MP3
Similar videos
-
3:48
ecc 2015: checkmate 025 trial showed nivolumab improved overall survival in advanced kidney cancer
-
1:58
dr. plimack on significance of checkmate-025 trial in rcc
-
3:29
emerging roles of nivolumab and cabozantinib for renal cell carcinoma
-
1:14
dr. choueiri on significance of checkmate-025 study for rcc
-
1:33
checkmate 920: nivolumab plus ipilimumab for renal cell cancer
-
0:47
checkmate 171: phase 2 trial of nivolumab for advanced squamous cell non-small cell lung cancer
-
5:06
phase 3 checkmate - 214
-
2:31
changing the standard of care in previously treated metastatic renal cell carcinoma
-
1:46
clinical trials in kidney cancer to look out for
-
2:12
comment: new immunotherapy options for kidney cancer
-
6:52
nivolumab in renal cell carcinoma
-
2:01
checkmate 172 trial of nivolumab for advanced melanoma: preliminary results
-
1:59
real-world vs. clinical trial: efficacy of nivolumab in mrcc
-
1:40
phase iii meteor trial: cabozantinib vs everolimus for advanced clear cell renal cell carcinoma
-
2:30
checkmate 214 trial update
-
5:59
prosper rcc study of perioperative nivolumab for renal cell carcinoma - future trial
-
2:25
dr. motzer on a phase ii trial of nivolumab for mrcc
-
2:27
changing the standard of care in previously treated metastatic renal cell carcinoma
-
2:02
tki and checkpoint inhibitor combinations for kidney cancer: the immotion151 trial